Some Savvy Investors Have Earned Up To 4,900% On Stocks In This Sector…

Hemp and Medical Marijuana, or “Pot” stocks as they are affectionately named, have been one of the most talked about subjects this year.

In fact, some of these stocks have seen gains of up to 200% almost overnight, with some as high as 1,700% in the short-term.

And who says you can’t make great money in Penny Stocks?  We’ll save that discussion for another article…

But, back to the Hemp and Medical Marijuana craze.

As with any hot topic, hot tip, hot stock, or hot anything that skyrockets and shows that we live in a dynamic world where things change rapidly sometimes good and sometimes not so good, and challenges an old way of thinking, there are always the gloom and doomers who climb out of the woodwork just to throw cold water on the party and make their claim that they, and they alone, have all the answers.

They claim to know everything about the market, have seen this before, wouldn’t invest in these stocks, and of course try to scare everyone away as they just have to be “right” all the time. You’d think they’d all be billionaires but usually, they are just naysayers or journalists.

On the other hand, there are the proponents of Hemp and Medical Marijuana stocks who think that every single stock that even remotely has anything to do with Medical Marijuana will blast off and create huge profits no matter what.

So, who’s right and how can you find the right companies to invest in whether short or long term?

It all started in November 2012 when the states of Colorado and Washington approved legislation to legalize both the medical and recreational use of marijuana.

“In the last year, the rise of the cannabis industry went from an interesting cocktail conversation to being taken seriously as the fastest growing industry in America,”  Troy Dayton, CEO of The ArcView Group.

Dayton of the Arc View Group, publisher of the third edition of the State of Legal Marijuana Markets, said in the executive summary of the report. “At this point, it’s hard to imagine that any serious businessperson who is paying attention hasn’t spent some time thinking about the possibilities in this market.”

The report projects a marijuana industry that could be more valuable than the entire organic food industry — that is if the legalization trend continues to the point that all 50 states legalize recreational marijuana.

The total market value of all states legalizing marijuana would top $36.8 billion — more than $3 billion larger than the organic food industry.

“These are exciting times,” Dayton said in the executive summary, “and new millionaires and possibly billionaires are about to be made, while simultaneously society will become safer and freer.”


At present, there are 26 states and the District of Columbia that have legalized Marijuana in some form.  Three additional states will soon join them after passing Measures on the November ballot legalizing the use of medical marijuana.

Seven states and the District of Columbia have adopted more expansive laws legalizing marijuana for recreational use.  In November, California, Massachusetts and Nevada all passed measures legalizing recreational marijuana.

California’s Proposition 64 measure allows adults 21 and older, to now possess up to one ounce of marijuana and grow up to six plants in their homes.  And the stock world is getting a taste of what legal marijuana and its ancillary businesses can generate… and the market loves it.

Many, many individuals have profited from these stocks with numerous days closing with near 100% gains. That’s just a fact and it’s undeniable.


Here are a few more facts:

  1. Marijuana and Hemp are the largest cash crop in the world, even before any legalization took place.
  2. There is a huge demand for Hemp and Medical Marijuana that is almost insatiable.
  3. The Hemp and medical marijuana industry is still virtually an untapped market… with lots of room for new and innovative companies that could produce huge gains for investors.

newuscannabisretailsalesprojections431So, it’s an undeniable fact that many Pot stocks have done incredibly well this year and that many investors have profited greatly, and very quickly. Regardless of what some pundits may say.

The question now is which of these companies have the best potential to stick around and continue to offer these opportunities and payoffs?


Because our job at Best Marijuana Stock is to present the facts and make suggestions about choices and options that consumers have and to help our readers to succeed in all aspects of their lives, we put together a well-researched checklist and offer our suggestions.

Here is what we would look for in a “Pot” stock and why, and we’ll even name a few companies we think you can profit very well from:

  1. Does the company currently have a popular product, or products that they sell and do they create an increasing revenue stream?
  2. Does the company have consistent trading volume?  Is there a strong market for the stock?
  3. Does the company have a low market cap or trade at a low multiple of revenues?
  4. Does the company have solid share structure?
  5. Does the company market itself well and does it have the management team to succeed?
  6. Does the company have the vision, ambition, and ability to carry out its stated goals?

Of many publicly traded companies in the industry, only one investment opportunity garnered five stars.


With today’s positive economic outlook for the industry and the naturally built-in customer base for products, a promising company entering the market should be taken seriously.

When we look at the profile above it is our belief that the companies that meet these criteria will be companies that should be on your radar or your “watch” list now.

In fact, we offer a few below that we have looked into extensively, have contacted, and in some cases even purchased products from.  We have also reviewed thoroughly what is being reported about these companies and even rate them for you:

#1.) Ubiquitech Software Corp.  (UBQU)

#2.) Terra Tech Corp.  (TRTC)

#2.) Rocky Mountain High Brands, Inc. (RMHB)

#4.) Medical Marijuana Inc. (MJNA)

#5.) Cannagrow Holdings, Inc. (CGRW)

#1.) Ubiquitech Software Corp. OTC:UBQU

Ubiquitech Software Corp. and its subsidiary HempLife Today / (Symbol: UBQU). This company has an amazing concept, name, and vision.

The Company focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring.™ has developed two award-winning lines of CannazALL™ CBD Oil.

CBD – or “cannabidiol” to the medical community is the game-changing component in OTC:UBQU subsidiary company HempLife Today’s proprietary CannazALL™ products.  CBD oil is simply the most exciting development currently coming out of the Hemp and related products industry.

It is considered to be a ‘miracle’ supplement for a wide range of common ailments such as seizures, anxieties, arthritis, sleep disorders, pain, and even cancer.  

And while hemp produces the exact same Cannabinoid molecules as its sister plant, hemp does not produce any psycho-actives, meaning users will NOT get “high”.

CBD may be the key to unlocking the cure to many different ailments.

Want to Invest?

The Company’s products are becoming a more widely accepted form of therapy, and this education of the public is showing an exponential growth in awareness of these products.

In fact, it is estimated that less than 5% of the general public is even aware of what CBD Oil is, what it does. The Company has a visionary management team with strong marketing skills.

UBQU has 185,308,000 shares outstanding ( and trades around $.03 with a current market cap of approximately $3,750,000.  The Company reported $3,493,000 in revenues for the most recent fiscal year.  Despite spending heavily to begin a sales ramp-up, UBQU earned a profit $334,000 versus only $39,000 for the prior year period.

The Company is projecting a 55% increase in revenues to $5,450,000 in the current fiscal year.  These are exceptionally good numbers for a company that is just getting started.

Other companies in burgeoning, high-growth sectors trade for 10 to 50 times revenues or more.  At just 10x expected year-end sales, UBQU shares would trade for nearly $.30 per share, approximately a -15-fold increase from their current value.


#2.) Terra Tech Corp. OTC:TRTC

Terra Tech Corp. / (Symbol: TRTC). Terra Tech Corp. operates through multiple subsidiary businesses including: Blum, IVXX Inc., Edible Gardens, MediFarm LLC and GrowOp Technology.

Blum’s retail medical cannabis facilities focus on providing the highest quality medical cannabis to patients who are looking for alternative treatments for their chronic medical conditions.

Blum offers a broad selection of medical cannabis products including; flowers, concentrates and edibles through its Oakland, CA and multiple Nevada locations.

IVXX, Inc. is a wholly-owned subsidiary of Terra Tech that produces medical cannabis-extracted products for regulated medical cannabis dispensaries throughout California.

The Company’s wholly-owned subsidiary, Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce.

Terra Tech’s MediFarm LLC subsidiaries are focused on medical cannabis cultivation and permitting businesses throughout Nevada. The Company’s wholly-owned subsidiary GrowOp Technology, specializes in controlled environment agricultural technologies.


Want to Invest?

TRTC has just shy of 573,000,000 shares outstanding ( and trades around $.27 per share with a current market cap of $154,710,000.  The Company reported $18,198,441 in revenues for the most recent nine months versus $7,805,994 a year ago – a significant increase.

However, the Company has a low gross margin on its products, has high administrative expenses and recorded a loss for the period of ($14,648,061).  TRTC has made significant sales gains, but needs to get its cost structure in line.  Continued improvements in revenues and cost reductions could lead to TRTC trading at a higher multiple of sales.


#3.) Rocky Mountain High Brands, Inc OTC:RMHB

Rocky Mountain High Brands, Inc. / RMHB). is a Dallas-based consumer goods brand development company that specializes in the development, manufacture, marketing, and distribution of high quality, health conscious, hemp-infused food and beverage products.

The Company currently markets a lineup of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low-calorie Coconut Lime Energy drink. Rocky Mountain High Brands also offers hemp-infused 2oz.

Mango Energy Shots and Mixed Berry Energy Shots, as well as a new Relaxation Brownie.  The Company recently launched a naturally high alkaline spring water, Eagle Spirit Spring Water.

Want to Invest?

RMHB has 623,097,784 shares outstanding ( and trades for around $.0388 per share with a current market cap of about $23,677,000.

The Company reported revenues of $1,075,000 for the year ended June 30, 2016, and an operating loss of ($3,709,000) for the period versus $490,000 in revenues for the year-earlier period and an operating loss of ($4,074,000).

RMHB is starting to see ramped-up sales growth but the high share count means that it already has a significant market capitalization for a company its size.  Continued rapid sales growth could lead to profits and share appreciation for RMHB.


#4.) Medical Marijuana Inc. OTC:MJNA

Medical Marijuana Inc. / (Symbol: MJNA) is comprised of a portfolio of products, services, technology, and businesses solely focused on the cannabis and hemp industries.

These products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high-value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries.

The Company’s services are extensive and varied, ranging from medical clinic management to the capitalization and development of existing industry business and product leaders.

Services include the development of cannabinoid based health and wellness products and the development of medical grade compounds.

MJNA provides over 85 proprietary and patented cannabinoid delivery methods. MJNA services include the licensing of its proprietary testing, genetics, labeling, and packaging, tracking,  production and standardization methods for the medicinal herb industry.

Medical Marijuana Inc.’s patented and proprietary technologies include the only pharmaceutical grade vertical Bio-Technology Company specializing in the standardization, production and extraction of phytocannabinoids.

Want to Invest?

MJNA has 3,025,841,854 shares outstanding ( and trades at $.125 per share with a current market cap of $378,230,231.  The Company reported $2,188,671 in revenue for the three months ended September 30, 2016 versus $1,845,575 in the year ago period.  MJNA recorded a loss of ($4,286,818) for the period this year and ($7,300,305) for the same period last year.

Losses were primarily the result of investment write-downs, financing, and litigation.  MJNA has a heavily credentialed management and advisory team, but seems to lack focus by trying to dip its hand in too many aspects of the industry. With an already staggering market-cap, MJNA likely needs to get a handle on its expenses before it can see valuation improvement.


#5.) CannaGrow Holdings, Inc. OTC:CGRW

Cannagrow Holdings, Inc. / CGRW) has entered the Medical/Recreational Cannabis Industry as a Lessor, Liaison, and Consultant to licensed Growers providing them with turnkey Growing Facilities in the State of Colorado. The Company intends to expand this business model within this industry as business opportunities evolve.

CannaGrow Holdings, Inc. has stated that it “does not and will not, until such time as Federal law allows, grow, harvest, distribute or sell marijuana or any substance that violate the laws of the United States of America.” 

CGRW’s model is as a service and facilities provider to others in the industry, rather than as a grower or seller of cannabis products.

Want to Invest?

CGRW has 102,073,434 shares outstanding ( and trades at $1.45 per share with a current market cap of $148,006,480.  The Company reported only $30,000 in revenues for the nine months ended September 30, 2016, and $26,760 for the prior year period – both insignificant numbers.

The net losses were ($257,591) and ($261,111 before a gain on debt relief) respectively.  While the Company has just recently begun operations in the sector, the market cap appears steep considering the lack of operations.  CGRW will need to show major sales increases in order to sustain its current valuation.



The Verdict: Ubquitech Software Corp. (UBQU) takes the top spot.

UBQU with its HempLife Today division and CannazALL™ brand offers investors the greatest potential for significant gains. UBQU’s increasing brand recognition, expanding product offerings, growing revenues, with a corresponding handle on expenses, and strong management team with a clear vision make it stand out above the rest.

The added benefit of consistent trading volume and an extremely low relative market valuation make UBQU a 5 Star Stock.

What’s Next? is proud to bring you this information as much time and energy were devoted to it. We hope that you enjoyed reading this article and that you learned something from it. We also hope that you find this information, like all the information on our site, useful, educational, and profitable.

If you would like to learn more about investing in MJ Stocks and discover 5 companies that make great investment opportunities put in your name below and we will email you the Marijuana Stock Review: 5 Leading Hemp and Medical Marijuana Stocks.








DISCLAIMER: This financial news and information portal (, and/or our newsletters contain commercial advertisements, and are for general entertainment purposes only. Along with the aggregation of timely financial news, we are engaged in the business of analyzing, marketing and advertising companies for monetary compensation. Unless otherwise stated below, the paying Third Party for our services may own shares and may liquidate them during any and all advertising periods. This disclaimer is to be read and fully understood before using, or joining one of our newsletter lists. We also encourage you to read the SEC INVESTOR ALERT before reading content found on and/or our newsletters. You are reading content found on our financial news and informational portal because you have clicked on an advertisement found on one of many marketing channels we advertise on. is for entertainment purposes only. We are NOT a source of unbiased information. Never invest in any stock featured on our site or newsletters unless you can afford to lose your entire investment. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled on the website/newsletter and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead, strongly urges you to supplement the information obtained from this website/newsletter with a complete and independent investigation of the companies discussed and a consideration of all pertinent risks. Investing in securities, including the securities of the companies profiled or discussed on this website/newsletter, is highly speculative and carries a high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies discussed. The information found on, and/or our newsletters are based on sources, which we believe to be reliable, but are not guaranteed by us as being accurate and do not purport to be a complete statement or summary of the available data. encourages readers and investors to supplement the information found on our site or in our newsletters with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources. makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the featured companies None of the owners of, or any of its directors, officers, employees, contractors, or affiliates is a licensed broker-dealer, account representative, market maker, investment banker, investment advisor, analyst or underwriter in any jurisdiction whatsoever. does not offer such advice or analysis, and further urges you to consult your own independent tax, business, financial and investment advisors before purchasing or selling any securities of the companies discussed on this website/newsletter. Compensation: may be compensated for up to seven-hundred and fifty thousand USD via bank wire by an unaffiliated Third Party for continuous analyzing, marketing and advertising services. does not own any shares of any featured company. The Third Party may own shares and may sell all, any or none of any shares held in any featured company during advertisement periods, which may negatively affect the featured company’s stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the featured company. and its employees, contractors, officers, directors, or affiliates may purchase shares on the open market of any mentioned featured company during advertisement periods and following the dissemination of any newsletters. This is an inherent conflict of interest. The services provided by this website/newsletter and its contents are provided “as is” and makes no representations or warranties of any kind with respect to this website/newsletter, its contents or its services. This website/newsletter has been prepared solely for the purpose of providing information about and the services it offers. This website/newsletter has been compiled in good faith by assumes no liability or responsibility for any errors or omissions in the content of this website/newsletter, any failures, delays, or interruptions in its services or any content contained on this website/newsletter, any losses or damages arising from the use of the content provided on this website/newsletter, or any conduct by users of’s services. reserves the right to add, modify or delete any information at this website/newsletter at any time. This website/newsletter may contain “forward-looking” information within the meaning of the Private Securities Litigation Reform Act of 1995. In accordance with the safe harbor provisions of this Act, statements contained herein that look forward in time that includes everything other than historical information, involve risks and uncertainties that may affect the companies’ actual results. There can be no assurance that such statements will prove to be accurate and there are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made in this report. Further specific financial information, filings, and disclosures as well as general investor information about the profiled companies, advice to investors and other investor resources are available at the Securities and Exchange Commission (“SEC”) website and the Financial Industry Regulatory Authority (“FINRA”) website at undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise. In addition to information about the company discussed, from time to time, this website/newsletter may contain the symbols of companies and/or news feeds or links to websites about companies that are not being discussed by us but are merely illustrative of certain activity in the stock market that we are highlighting (so-called hyperlinks to third party websites or access to third party content). Readers are advised that all links and access to these sites and content solely for informational purposes., its owners, directors, officers, employees, affiliates, and contractors are not responsible for errors and omissions nor does control, endorse, or guarantee any content found in such sites or content. Any opinions expressed are subject to change without notice. It is also possible that the companies discussed on those sites may not have approved certain or any statements within the report. By accessing or viewing this website/newsletter, you agree that, its owners, directors, officers, employees, affiliates and contractors are not responsible for any content, associated links, resources, or services associated with a third-party website. uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. In no event shall, its owners, directors, officers, employees, affiliates and contractors be liable (jointly or severally) for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with this website/newsletter. You agree to hold, its owners, directors, officers, employees, affiliates and contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of the information contained on this website/newsletter (including any loss or damage of any sort associated with your use of third party content). You agree that use of this website/newsletter is at your sole risk. disclaims all warranties of any kind, express or implied. If any applicable authority holds any portion of this section to be unenforceable, then liability will be limited to the fullest possible extent permitted by applicable law. encourages readers to invest carefully, and read investor and issuer information available at the websites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at and filings made by public companies can be viewed at . In addition, FINRA has published information at its website on how to invest carefully at Questions regarding any information contained on this website/newsletter may be sent to To review’s website and its disclaimer, please visit